A future for hyperthermia in cancer treatment?

European Journal of Cancer

Volumn 37, Issue 13, 2001, Pages 1587-1589

  Nielsen, O S ^a   Horsman, M ^a   Overgaard, J ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE;

ADJUVANT CHEMOTHERAPY; ANGIOGENESIS; CANCER CONTROL; CANCER RISK; CANCER SURVIVAL; CLINICAL TRIAL; HUMAN; HYPERTHERMIC THERAPY; LIMB PERFUSION; META ANALYSIS; METHODOLOGY; PRIORITY JOURNAL; SHORT SURVEY; SOFT TISSUE SARCOMA; TEMPERATURE SENSITIVITY; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0034890465     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(01)00193-9     Document Type: Editorial

References (24)

1. History and heritage - An introduction
2. Therapeutische Erfahrungen an 100 mit kombination von Röntgenstrahlen und Hochfreqenz, resp Diathermie behandelten bösartigen Neubildungen
3. Hyperthermia
4. The current and potential role of hyperthermia in radiotherapy
5. Hyperthermic radiosensitization: Mode of action and clinical relevance
6. Hyperthermia in oncology
7. Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma European Society for Hyperthermic Oncology
8. Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: Results from five randomized controlled trials
9. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: A prospective, randomised, multicentre trial
10. A randomized clinical trial of radiation therapy versus thermoradiotherapy in stage IIIB cervical carcinoma
11. Prophylactic isolated limb perfusion for localized, high-risk limb melanoma: Results of a multicenter randomized phase III trial European Organization for Research and Treatment of Cancer Malignant Melanoma Cooperative Group Protocol 18832, the World Health Organization Melanoma Program Trial 15, and the North American Perfusion Group Southwest Oncology Group-8593
12. Heat-inducible vectors for use in gene therapy
13. Heat-induced gene expression as a novel targeted cancer gene therapy strategy
14. Induction of vascular endothelial growth factor (VEGF) by hyperthermia and/or an angiogenesis inhibitor
15. Improving local tumor control by combining vascular targeting drugs, mild hyperthermia and radiation
16. Neoadjuvant chemotherapy combined with regional hyperthermia (RHT) for locally advanced primary or recurrent high-risk soft tissue sarcomas (STS) of adults: Long-term results of a phase II study
17. Treatment of primary, recurrent or inadequately resected high-risk soft tissue sarcomas (STS) of adults: Result of a phase II pilot study (RHT-95) of neoadjuvant chemotherapy combined with regional hyperthermia
18. Randomised prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity
19. Adjuvant chemotherapy for adult soft-tissue sarcoma: Is there a standard of care?
20. Adjuvant chemotherapy for soft-tissue sarcoma - Current status
21. Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: Meta-analysis of individual data
22. Adjuvant chemotherapy for adult soft-tissue sarcoma of the extremities and girdles: Results of the Italian randomised cooperative trial
23. Association of local recurrence with subsequent survival in extremity soft tissue sarcoma
24. Prognostic factors predictive of survival and local recurrence for extremity soft tissue sarcoma